TITLE:
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

CONDITION:
Rhinitis, Allergic, Seasonal

INTERVENTION:
MK0476, montelukast sodium

SUMMARY:

      The purpose of this study is to determine the effect of an approved medication on the
      symptoms of seasonal allergic rhinitis (a seasonal variety of inflammation of the mucous
      membrane of the nose) in patients who are experiencing symptoms of seasonal allergic
      rhinitis and asthma.
    

DETAILED DESCRIPTION:

      The duration of treatment is 2 weeks.
    

ELIGIBILITY:
Gender: All
Age: 15 Years to 85 Years
Criteria:

        Inclusion Criteria:

          -  Non-smoker

          -  A 2-year documented history of seasonal allergic rhinitis

          -  A 1-year documented history of chronic asthma

          -  Positive allergy testing

        Exclusion Criteria:

          -  Medical history of a lung disorder (other than asthma) or a recent upper respiratory
             tract infection.
      
